Neftaly: Integrating Biomarkers into Health System Performance Assessments

Introduction

As health systems across the globe strive to become more responsive, efficient, and equitable, performance assessment tools must evolve accordingly. Biomarkers—objective, measurable indicators of biological processes—offer a transformative opportunity to improve how we assess, monitor, and optimize health system performance.

At Neftaly, we support governments, researchers, and health institutions in integrating biomarkers into system-wide evaluation strategies to drive smarter policies and better outcomes.

Why Biomarkers Matter for System Performance

Biomarkers provide quantifiable, real-time data on population health, disease burden, treatment response, and care quality. When integrated into performance assessments, they offer:

• Early warning signals of disease outbreaks or health deterioration
• Precision monitoring of chronic disease management (e.g., HbA1c for diabetes)
• Objective outcome measures for evaluating interventions or services
• Insights into equity, identifying disparities in access to diagnostic and treatment services

Strategic Areas for Integration

1. Health Surveillance and Monitoring

Biomarkers can enhance national surveillance systems by:

• Tracking infectious disease markers (e.g., viral load in HIV)
• Monitoring environmental exposures (e.g., lead levels in children)
• Supporting real-time data collection for outbreak response

2. Quality of Care Measurement

Health systems can use biomarkers to evaluate:

• Treatment effectiveness (e.g., tumor markers to assess cancer therapies)
• Compliance with clinical guidelines (e.g., LDL-C levels in cardiovascular care)
• Patient safety and adverse events (e.g., liver function biomarkers during drug therapy)

3. Equity and Access Assessment

Biomarker data can reveal disparities by:

• Analyzing coverage gaps in diagnostic services across regions
• Assessing delayed diagnoses due to limited testing access
• Identifying population-specific needs (e.g., genetic markers in underrepresented groups)

4. Health System Resilience and Preparedness

Biomarkers help evaluate a system’s capacity to respond to crises:

• Measuring baseline health vulnerabilities (e.g., micronutrient biomarkers during food crises)
• Assessing biomarker trends before, during, and after public health emergencies
• Tracking system recovery through biomarker-based outcome data

Best Practices for Integration

1. Establish National Biomarker Frameworks
   Align biomarker selection with health priorities and performance goals.
2. Strengthen Data Systems
   Integrate biomarker data into electronic health records, health information systems, and national dashboards.
3. Ensure Quality and Standardization
   Use validated biomarkers, accredited laboratories, and quality control protocols to ensure accuracy and comparability.
4. Build Capacity
   Train healthcare workers and analysts to interpret and use biomarker data for decision-making.
5. Promote Multi-sectoral Collaboration
   Involve public health agencies, academia, private labs, and community organizations in planning and implementation.

Neftaly’s Role

Neftaly supports countries and partners by:

• Developing biomarker-informed performance indicators
• Providing policy guidance on ethical use, data protection, and equity
• Training programs for data analysts, policymakers, and frontline health workers
• Facilitating cross-country learning, sharing case studies, and supporting innovation

Conclusion

Integrating biomarkers into health system performance assessments is a critical step toward more accountable, adaptive, and equitable healthcare. By linking clinical science with system-wide analytics, we can better understand what works, where gaps exist, and how to build resilient systems for the future